MBX
NASDAQ
$60.14
MBX Biosciences Inc (MBX)
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. The company is headquartered in Carmel, Indiana.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $69 (+14.73%)
Market Cap
$2.89B
Free Cash Flow Yield
-2.77%
Beta (5Y)
1.44
Price Chart
Valuation
Market Cap$2.89B
P/B6.15
Profitability
EBITDA-$160M
EPS-$3.49
Financial Health
Free Cash Flow Yield-2.77%
Growth & Risk
Beta (5Y)1.44
Sharpe Ratio1.69